Apoptosis and emphysema: the missing link.

Department of Pathology, Division of Cardiopulmonary Pathology, and Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Section of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; Division of Pulmonary and Critical Care Medicine, and COPD Center, Department of Medicine, University of Colorado School of Medicine, Denver, Colorado; and Program in Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado

[1]  N. Voelkel,et al.  Methylprednisolone causes matrix metalloproteinase-dependent emphysema in adult rats. , 2003, American journal of respiratory and critical care medicine.

[2]  K. Aoshiba,et al.  Alveolar wall apoptosis causes lung destruction and emphysematous changes. , 2003, American journal of respiratory cell and molecular biology.

[3]  N. Kaminski,et al.  Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema , 2003, Nature.

[4]  N. Voelkel,et al.  Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. , 2003, American journal of respiratory cell and molecular biology.

[5]  D. Green,et al.  Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis , 2003, The Journal of cell biology.

[6]  M. Shibuya,et al.  MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.

[7]  N. Voelkel,et al.  Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[8]  Dean P. Jones,et al.  Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in HL60 cells that overexpress Bcl‐2 , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Till Acker,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.

[10]  K. Brown,et al.  Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. , 2002, The Journal of clinical investigation.

[11]  T. Galeotti,et al.  Reactive Oxygen Species as Downstream Mediators of Angiogenic Signaling by Vascular Endothelial Growth Factor Receptor-2/KDR* , 2002, The Journal of Biological Chemistry.

[12]  E. Kasahara,et al.  Antioxidant protection of propofol and its recycling in erythrocyte membranes. , 2002, American journal of respiratory and critical care medicine.

[13]  V. Fadok,et al.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. , 2002, The Journal of clinical investigation.

[14]  V. Fadok,et al.  Apoptotic cell removal , 2001, Current Biology.

[15]  V. Fadok,et al.  Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. , 2001, The Journal of clinical investigation.

[16]  T. Mak,et al.  Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). , 2001, The Journal of clinical investigation.

[17]  A. Ishida,et al.  Expression of vascular endothelial growth factor receptors in smooth muscle cells , 2001, Journal of cellular physiology.

[18]  V. Fadok,et al.  The phosphatidylserine receptor: a crucial molecular switch? , 2001, Nature Reviews Molecular Cell Biology.

[19]  M. Cosio,et al.  Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. , 2001, The European respiratory journal.

[20]  J. D’Armiento,et al.  Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. , 2001, American journal of respiratory and critical care medicine.

[21]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[22]  W. MacNee,et al.  Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? , 2001, Trends in molecular medicine.

[23]  K. Shitara,et al.  and surface marker for the lineage of monocyte-macrophages in humans Flt-1 , vascular endothelial growth factor receptor 1 , is a novel cell , 2001 .

[24]  R. Homer,et al.  Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung , 2000, The Journal of experimental medicine.

[25]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[26]  S. Shapiro,et al.  Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new data. , 2000, The Journal of clinical investigation.

[27]  B. Ma,et al.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.

[28]  John Savill,et al.  Corpse clearance defines the meaning of cell death , 2000, Nature.

[29]  J. Downward,et al.  Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling , 2000, Oncogene.

[30]  J. Martinou,et al.  Mitochondria as the central control point of apoptosis. , 2000, Trends in cell biology.

[31]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[32]  M Ikegami,et al.  Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Hydén,et al.  A receptor for phosphatidylserine-speci ® c clearance of apoptotic cells , 2000 .

[34]  P. Stang,et al.  The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. , 2000, Chest.

[35]  R. Nagai,et al.  Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases , 2000, Cellular and Molecular Life Sciences CMLS.

[36]  M. Gaxiola,et al.  Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.

[37]  S. Nagata,et al.  Fas ligand-induced apoptosis. , 1999, Annual review of genetics.

[38]  P. Jeffery.  Chairman's Summary , 1999 .

[39]  T. Huang,et al.  CpG island arrays: an application toward deciphering epigenetic signatures of breast cancer , 1999, Nature Genetics.

[40]  M. Marrero,et al.  Vascular Endothelial Growth Factor Signals Endothelial Cell Production of Nitric Oxide and Prostacyclin through Flk-1/KDR Activation of c-Src* , 1999, The Journal of Biological Chemistry.

[41]  B. Krammer,et al.  Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. , 1999, Journal of immunology.

[42]  S. Korsmeyer,et al.  BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.

[43]  E. Kandel,et al.  Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria , 1999, Molecular and Cellular Biology.

[44]  K. Goss,et al.  Vascular endothelial growth factor gene expression in human fetal lung in vitro. , 1999, American journal of respiratory cell and molecular biology.

[45]  Vishva Dixit,et al.  Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.

[46]  R K Jain,et al.  Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Clauss,et al.  Functions of the VEGF receptor-1 (FLT-1) in the vasculature. , 1998, Trends in cardiovascular medicine.

[48]  V. Dixit,et al.  Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.

[49]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[50]  B. Ames,et al.  The free radical theory of aging matures. , 1998, Physiological reviews.

[51]  V. Fadok,et al.  Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. , 1998, The Journal of clinical investigation.

[52]  M. Gorospe,et al.  p27Kip1 overexpression causes apoptotic death of mammalian cells , 1997, Oncogene.

[53]  R. Voll,et al.  Immunosuppressive effects of apoptotic cells , 1997, Nature.

[54]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[55]  L. O’Driscoll,et al.  Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. , 1997, American journal of respiratory and critical care medicine.

[56]  F. Chu,et al.  Neutrophil migration through preexisting holes in the basal laminae of alveolar capillaries and epithelium during streptococcal pneumonia. , 1995, Microvascular research.

[57]  J. Stone,et al.  Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.

[58]  N. Voelkel,et al.  Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. , 1995, The Journal of clinical investigation.

[59]  M. Shibuya,et al.  Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. , 1994, The Journal of biological chemistry.

[60]  K. Alitalo,et al.  Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. , 1994, The Journal of biological chemistry.

[61]  Z. Oltvai,et al.  Bcl-2 functions in an antioxidant pathway to prevent apoptosis , 1993, Cell.

[62]  E. Oldfield,et al.  Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. , 1993, The American journal of physiology.

[63]  Y. Okada,et al.  Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema , 1992, Cell.

[64]  G. Lungarella,et al.  A 16-month study of the development of genetic emphysema in tight-skin mice. , 1989, The American review of respiratory disease.

[65]  S. Eriksson,et al.  Alpha 1-antitrypsin deficiency: lessons learned from the bedside to the gene and back again. Historic perspectives. , 1989, Chest.

[66]  J. Hogg,et al.  Morphology of peripheral airways in current smokers and ex-smokers. , 2015, The American review of respiratory disease.

[67]  K. Ohlsson,et al.  The induction of pulmonary emphysema with human leukocyte elastase. , 2015, The American review of respiratory disease.

[68]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.